![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Influenza |
Free Subscription
2 Arch Virol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea
compounds in vitro.
Arch Virol. 2022;167:1547-1557.
PubMed
Abstract available
Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon.
Arch Virol. 2022;167:1509-1519.
PubMed
Abstract available
A high-affinity aptamer with base-appended base-modified DNA bound to isolated
authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant).
Biochem Biophys Res Commun. 2022;614:207-212.
PubMed
Abstract available
Fetal neurodevelopmental spatio-temporal dynamic transcriptional landscape of
maternal insult-induce autism spectrum disorder risk.
Biochem Biophys Res Commun. 2022;614:183-190.
PubMed
Abstract available
Convergent Evolution of Multiple Mutations Improves the Viral Fitness of
SARS-CoV-2 Variants by Balancing Positive and Negative Selection.
Biochemistry. 2022;61:963-980.
PubMed
Abstract available
Sigmoid colon perforation in a SARS-CoV-2 positive neonate: a uniqueness report
and a brief review.
BMC Pediatr. 2022;22:327.
PubMed
Abstract available
Three more points about Paxlovid for covid-19.
BMJ. 2022;377:o1397.
PubMed
Covid-19: Doctor who sold hydroxychloroquine as "magic bullet" treatment is
jailed.
BMJ. 2022;377:o1395.
PubMed
Private cancer provider collapses despite drive to tackle NHS backlog.
BMJ. 2022;377:o1401.
PubMed
How are vaccines being adapted to meet the changing face of SARS-CoV-2?
BMJ. 2022;377:o1257.
PubMed
Covid-19: Two million people in the UK are estimated to be experiencing long
covid, says ONS.
BMJ. 2022;377:o1391.
PubMed
Protective effect of a first SARS-CoV-2 infection from reinfection: a matched
retrospective cohort study using PCR testing data in England.
Epidemiol Infect. 2022;150:e109.
PubMed
Abstract available
Respiratory viral infections in otherwise healthy humans with inherited IRF7
deficiency.
J Exp Med. 2022;219.
PubMed
Abstract available
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being
Boosted in a Phase 1 Open-Label Trial.
J Infect Dis. 2022 Jan 25. pii: 6515374. doi: 10.1093.
PubMed
Abstract available
SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential
Cross-Neutralization of Established and Emerging Strains Including Delta and
Omicron.
J Infect Dis. 2022;225:1909-1914.
PubMed
Abstract available
Neutralizing response against SARS-CoV-2 variants 8 months after BNT162b2
vaccination in naive and COVID-19 convalescent individuals.
J Infect Dis. 2021 Dec 28. pii: 6486499. doi: 10.1093.
PubMed
Abstract available
Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and
hospitalization in older adults.
J Infect Dis. 2021 Dec 28. pii: 6486498. doi: 10.1093.
PubMed
Abstract available
Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in
people with well-controlled HIV and a comparable cohort of people without HIV.
J Infect Dis. 2021 Dec 20. pii: 6470931. doi: 10.1093.
PubMed
Abstract available
Genetic Determinants for Virulence and Transmission of the Panzootic Avian
Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks.
J Virol. 2022 Jun 7:e0014922. doi: 10.1128/jvi.00149.
PubMed
Abstract available
Warning Against Counterfeit At-home COVID-19 Tests.
JAMA. 2022;327:2067.
PubMed
Characteristics and Outcomes of Hospitalized Patients in South Africa During the
COVID-19 Omicron Wave.
JAMA. 2022;327:2147-2148.
PubMed
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19.
JAMA. 2022;327:2149.
PubMed
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19.
JAMA. 2022;327:2148-2149.
PubMed
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19.
JAMA. 2022;327:2149-2150.
PubMed
Characteristics and Outcomes of Hospitalized Patients in South Africa During the
COVID-19 Omicron Wave-Reply.
JAMA. 2022;327:2148.
PubMed
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19-Reply.
JAMA. 2022;327:2150-2151.
PubMed
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With
COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
JAMA. 2022 May 15. pii: 2792506. doi: 10.1001/jama.2022.7993.
PubMed
Abstract available
Need for improved global measurement of early childhood respiratory syncytial
virus disease.
Lancet. 2022;399:1993-1995.
PubMed
Global, regional, and national disease burden estimates of acute lower
respiratory infections due to respiratory syncytial virus in children younger
than 5 years in 2019: a systematic analysis.
Lancet. 2022;399:2047-2064.
PubMed
Abstract available
Transforming or tinkering: the world remains unprepared for the next pandemic
threat.
Lancet. 2022;399:1995-1999.
PubMed
Global health diplomacy-reconstructing power and governance.
Lancet. 2022 May 17. pii: S0140-6736(22)00583.
PubMed
Abstract available
Shanghai's life-saving efforts against the current omicron wave of the COVID-19
pandemic.
Lancet. 2022 May 6. pii: S0140-6736(22)00838.
PubMed
COVID-19 Cases, Hospitalizations, and Deaths Among American Indian or Alaska
Native Persons - Alaska, 2020-2021.
MMWR Morb Mortal Wkly Rep. 2022;71:730-733.
PubMed
Abstract available
Audio Interview: Dissecting the Host Response to SARS-CoV-2.
N Engl J Med. 2022;386:e69.
PubMed
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2201300.
PubMed
Abstract available
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2202261.
PubMed
Abstract available
Does the World Still Need New Covid-19 Vaccines?
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMe2204695.
PubMed
Bypassing shortages of personal protective equipment in low-income settings using
local production and open source tools.
PLoS Biol. 2022;20:e3001658.
PubMed
Abstract available
Anatomy of the first six months of COVID-19 vaccination campaign in Italy.
PLoS Comput Biol. 2022;18:e1010146.
PubMed
Abstract available
Relationship between the Bolsa Familia national cash transfer programme and
suicide incidence in Brazil: A quasi-experimental study.
PLoS Med. 2022;19:e1004000.
PubMed
Abstract available
A mixed-methods study on health learning materials utilization for COVID-19 risk
communication and community engagement among health workers in Arsi Zone,
Ethiopia: Implication for response to pandemic.
PLoS One. 2022;17:e0269574.
PubMed
Abstract available
Auxology of small samples: A method to describe child growth when restrictions
prevent surveys.
PLoS One. 2022;17:e0269420.
PubMed
Abstract available
Using Google Health Trends to investigate COVID-19 incidence in Africa.
PLoS One. 2022;17:e0269573.
PubMed
Abstract available
Genetic subtyping and phylogenetic analysis of HA and NA from avian influenza
virus in wild birds from Peru reveals unique features among circulating strains
in America.
PLoS One. 2022;17:e0268957.
PubMed
Abstract available
Big data-based risk assessment of poultry farms during the 2020/2021 highly
pathogenic avian influenza epidemic in Korea.
PLoS One. 2022;17:e0269311.
PubMed
Abstract available
Experiences of personal protective equipment by Australian healthcare workers
during the COVID-19 pandemic, 2020: A cross-sectional study.
PLoS One. 2022;17:e0269484.
PubMed
Abstract available
Optimising the balance of acute and intermediate care capacity for the complex
discharge pathway: Computer modelling study during COVID-19 recovery in England.
PLoS One. 2022;17:e0268837.
PubMed
Abstract available
Cash stock strategies during regular and COVID-19 periods for bank branches by
deep learning.
PLoS One. 2022;17:e0268753.
PubMed
Abstract available
I'm wearing a mask, but are they?: Perceptions of self-other differences in
COVID-19 health behaviors.
PLoS One. 2022;17:e0269625.
PubMed
Abstract available
Noncommunicable diseases risk factors and the risk of COVID-19 among university
employees in Indonesia.
PLoS One. 2022;17:e0263146.
PubMed
Abstract available
The incidence and severity of COVID-19 in adult professional soccer players in
Russia.
PLoS One. 2022;17:e0265019.
PubMed
Abstract available
Risk factors for disease severity and increased medical resource utilization in
respiratory syncytial virus (+) hospitalized children: A descriptive study
conducted in four Belgian hospitals.
PLoS One. 2022;17:e0268532.
PubMed
Abstract available
Evaluation and prevention and control measures of urban public transport exposure
risk under the influence of COVID-19-Taking Wuhan as an example.
PLoS One. 2022;17:e0267878.
PubMed
Abstract available
The association between vitamin D status and COVID-19 in England: A cohort study
using UK Biobank.
PLoS One. 2022;17:e0269064.
PubMed
Abstract available
Identification of cardiovascular and molecular prognostic factors for the
morbidity and mortality in COVID-19-sepsis (ICROVID): Protocol for a prospective
multi-centre cohort study.
PLoS One. 2022;17:e0269247.
PubMed
Abstract available
Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A
systematic review and meta-analysis.
PLoS One. 2022;17:e0269368.
PubMed
Abstract available
Exponentiated Odd Lomax Exponential distribution with application to COVID-19
death cases of Nepal.
PLoS One. 2022;17:e0269450.
PubMed
Abstract available
Perception of the quality of remote lessons in the time of COVID-19: A
comparative study in Latin America quality of remote lessons in the context of
COVID-19.
PLoS One. 2022;17:e0268966.
PubMed
Abstract available
Study on the influence of COVID-19 on the growth of China's small and
medium-sized construction enterprises.
PLoS One. 2022;17:e0266315.
PubMed
Abstract available
Changes in physical activity, dietary and sleeping pattern among the general
population in COVID-19: A systematic review protocol.
PLoS One. 2022;17:e0269202.
PubMed
Abstract available
Psychological distress reported by healthcare workers in Saudi Arabia during the
COVID-19 pandemic: A cross-sectional study.
PLoS One. 2022;17:e0268976.
PubMed
Abstract available
Opinions and options about COVID-19: Personality correlates and sex differences
in two European countries.
PLoS One. 2022;17:e0268193.
PubMed
Abstract available
Knowledge, practice, and impact of COVID-19 on mental health among patients with
chronic health conditions at selected hospitals of Sidama regional state,
Ethiopia.
PLoS One. 2022;17:e0269171.
PubMed
Abstract available
The safety of co-administration of Bacille Calmette-Guerin (BCG) and influenza
vaccines.
PLoS One. 2022;17:e0268042.
PubMed
Abstract available
Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and
meta-analysis.
PLoS One. 2022;17:e0269273.
PubMed
Abstract available
Feasibility and lessons learned on remote trial implementation from TestBoston, a
fully remote, longitudinal, large-scale COVID-19 surveillance study.
PLoS One. 2022;17:e0269127.
PubMed
Abstract available
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for
optimal functionality as therapeutics.
PLoS One. 2022;17:e0267796.
PubMed
Abstract available
Impact of the COVID-19 pandemic on orthopaedic and traumatological care in
Prague, the capital of the Czech Republic.
PLoS One. 2022;17:e0269164.
PubMed
Abstract available
Hospitals early challenges and interventions combatting COVID-19 in the Eastern
Mediterranean Region.
PLoS One. 2022;17:e0268386.
PubMed
Abstract available
Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized
COVID-19 patients in Belgium.
PLoS One. 2022;17:e0269138.
PubMed
Abstract available
Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19.
PLoS One. 2022;17:e0268919.
PubMed
Abstract available
Cancer patients' satisfaction with telehealth during the COVID-19 pandemic.
PLoS One. 2022;17:e0268913.
PubMed
Abstract available
Experiences of COVID-19 infection in North Carolina: A qualitative analysis.
PLoS One. 2022;17:e0269338.
PubMed
Abstract available
Social connections at work and mental health during the first wave of the
COVID-19 pandemic: Evidence from employees in Germany.
PLoS One. 2022;17:e0264602.
PubMed
Abstract available
Doctoring from home: Physicians' perspectives on the advantages of remote care
delivery during the COVID-19 pandemic.
PLoS One. 2022;17:e0269264.
PubMed
Abstract available
Prognostic indicators and outcomes of hospitalised COVID-19 patients with
neurological disease: An individual patient data meta-analysis.
PLoS One. 2022;17:e0263595.
PubMed
Abstract available
Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A
systematic review.
PLoS One. 2022;17:e0265531.
PubMed
Abstract available
Construct validity of the Spanish version of the Post-COVID-19 Functional Status
scale and validation of the web-based form in COVID-19 survivors.
PLoS One. 2022;17:e0269274.
PubMed
Abstract available
Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island.
PLoS One. 2022;17:e0268587.
PubMed
Abstract available
Determinants of the COVID-19 vaccine hesitancy spectrum.
PLoS One. 2022;17:e0267734.
PubMed
Abstract available
COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance
among adult Africans.
PLoS One. 2022;17:e0268230.
PubMed
Abstract available
The relationship between voting restrictions and COVID-19 case and mortality
rates between US counties.
PLoS One. 2022;17:e0267738.
PubMed
Abstract available
Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine
olfaction.
PLoS One. 2022;17:e0268382.
PubMed
Abstract available
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted
with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial.
Vaccine. 2022 Jun 4. pii: S0264-410X(22)00677.
PubMed
Abstract available
Jabbing together? The complementarity between social capital, formal public
health rules, and COVID-19 vaccine rates in the United States.
Vaccine. 2022 May 19. pii: S0264-410X(22)00612.
PubMed
Abstract available
Experimental pre-tests of public health communications on the COVID-19 vaccine: A
null finding for medical endorsement, risk and altruism.
Vaccine. 2022 May 16. pii: S0264-410X(22)00613.
PubMed
Abstract available
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report
of interim findings.
Vaccine. 2022 May 13. pii: S0264-410X(22)00494.
PubMed
Abstract available
Decay of anti-Bordetella pertussis antibodies in women of childbearing age
following COVID-19 non-pharmaceutical measures.
Vaccine. 2022;40:3746-3751.
PubMed
Abstract available
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits
and social norms.
Vaccine. 2022 May 19. pii: S0264-410X(22)00567.
PubMed
Abstract available
Development of effective messages to promote maternal immunization in Kenya.
Vaccine. 2022;40:3761-3770.
PubMed
Abstract available
COVID-19 vaccine uptake and its associated factors among Palestinian healthcare
workers: Expectations beaten by reality.
Vaccine. 2022 May 13. pii: S0264-410X(22)00610.
PubMed
Abstract available
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron
variant. Report from a meeting of the World Health Organization.
Vaccine. 2022 May 2. pii: S0264-410X(22)00523.
PubMed
Abstract available
Identifying immunity gaps for measles using Belgian serial serology data.
Vaccine. 2022;40:3676-3683.
PubMed
Abstract available
Factors associated with the intention to participate in COVID-19 vaccine clinical
trials: A cross-sectional study in Peru.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00421.
PubMed
Abstract available
Acceptability of COVID-19 vaccine mandates among New York City parents, November
2021.
Vaccine. 2022 May 11. pii: S0264-410X(22)00580.
PubMed
Abstract available
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd
DCVMN Annual General Meeting.
Vaccine. 2022 May 13. pii: S0264-410X(22)00576.
PubMed
Abstract available
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus
vaccine expressing SARS-CoV-2 spike: Interim results of a randomized,
placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine. 2022 May 13. pii: S0264-410X(22)00526.
PubMed
Abstract available
Effects of vaccination status in the United States on willingness to undergo
surgery during a pandemic: A prospective survey study.
Vaccine. 2022 May 13. pii: S0264-410X(22)00583.
PubMed
Abstract available
Catch-up vaccination campaign in children between 6 and 8 years old during
COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Vaccine. 2022 May 12. pii: S0264-410X(22)00573.
PubMed
Abstract available
Impact of national Covid-19 vaccination Campaign, South Korea.
Vaccine. 2022 May 8. pii: S0264-410X(22)00572.
PubMed
Abstract available
Receptor-binding domain recombinant protein on alum-CpG induces broad protection
against SARS-CoV-2 variants of concern.
Vaccine. 2022;40:3655-3663.
PubMed
Abstract available
Covid-19 vaccine immunogenicity in people living with HIV-1.
Vaccine. 2022 May 5. pii: S0264-410X(22)00543.
PubMed
Abstract available
Building population and health system resilience: Using lessons learned during
the COVID pandemic to implement life-course immunisation policy.
Vaccine. 2022;40:3511-3513.
PubMed
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Vaccine. 2022;40:3484-3489.
PubMed
Abstract available
WHO preferred product characteristics for monoclonal antibodies for passive
immunization against respiratory syncytial virus (RSV) disease in infants - Key
considerations for global use.
Vaccine. 2022;40:3506-3510.
PubMed
Abstract available
Worldwide routine immunisation coverage regressed during the first year of the
COVID-19 pandemic.
Vaccine. 2022;40:3531-3535.
PubMed
Abstract available
Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2
prototypic, Delta and Omicron variant infection.
Virology. 2022;572:64-71.
PubMed
Abstract available
Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations
on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on
attributes developed by emerging variants of concern.
Virology. 2022;572:44-54.
PubMed
Abstract available
Immunoinformatic approach for the construction of multi-epitopes vaccine against
omicron COVID-19 variant.
Virology. 2022;572:28-43.
PubMed
Abstract available
Lebanese SARS-CoV-2 genomics: 24 months of the pandemic.
Virus Res. 2022;317:198824.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by